Table 1
Demographics and baseline data of patients in the stereotactic haematoma aspiration and best medical management group
| Stereotactic aspiration, n=142 (%) | Conservative treatment, n=78 (%) | P value | |
| Male | 82 (57.7) | 44 (56.4) | 0.848 |
Age (
, years) | 62.1±9.5 | 60.2±9.1 | 0.372 |
| History of hyperlipidaemia | 42 (29.6) | 24 (30.8) | 0.854 |
| History of diabetes | 26 (18.3) | 18 (23.1) | 0.398 |
| History of coronary heart disease | 5 (3.5) | 4 (5.1) | 0.724* |
| History of atrial fibrillation | 1 (0.7) | 0 (0) | – |
| History of stroke | 6 (4.2) | 2 (2.6) | 0.715* |
| Smoking | 76 (53.5) | 40 (51.3) | 0.750 |
| Alcohol abuse | 51 (35.9) | 30 (38.5) | 0.708 |
| Hypotensor | 107 (75.4) | 52 (66.7) | 0.169 |
| Warfarin treatment | 7 (4.9) | 5 (6.4) | 0.758* |
SBP (
, mm Hg) | 165.4±24.3 | 162.6±23.7 | 0.533 |
DBP (
, mm Hg) | 106.4±9.6 | 103.5±9.2 | 0.445 |
| ICH location | |||
| Basal ganglia | 74 (52.1) | 42 (53.8) | 0.805 |
| Thalamus | 57 (40.1) | 30 (38.5) | 0.807 |
| Lobar | 11 (7.7) | 6 (7.7) | 0.989 |
| Baseline ICH volume, median (IQR) mL | 31 (23–39) | 29 (21–37) | 0.122 |
| ICH score, median (IQR) | 2 (0–3) | 1 (0–1) | 0.021 |
| IVH presence | 34 (23.9) | 5 (6.4) | 0.001 |
| Midline shift | 125 (88.0) | 57 (64.0) | 0.000 |
| Admission GCS, median (IQR) | 10 (9–13) | 11 (9–14) | 0.034 |
Haemoglobin (
, g/L) | 105.2±14.1 | 108.4±13.6 | 0.226 |
| Blood glucose, median (IQR) | 8.8 (5.9–11.3) | 8.4 (6.1–10.8) | 0.157 |
| INR, median (IQR) | 1.0 (0.7–1.3) | 1.2 (0.7–1.4) | 0.204 |
Onset to the first CT time (min, 
) | 186.8±54.6 | 177.3±52.4 | 0.355 |
Onset to admission time (min, 
) | 171.4±52.2 | 162.8±49.24 | 0.115 |
*Fisher’s exact test.
DBP, diastolic blood pressure, 1 mm Hg=0.133 kPa; GCS, Glasgow Coma Scale; ICH, intracerebral haemorrhage; INR, International normalised ratio; IVH, intraventricular haemorrhage; SBP, systolic blood pressure.